FI952802A0 - Uudet tetrasykliset piperidiini- ja 1,4-oksatsiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset - Google Patents

Uudet tetrasykliset piperidiini- ja 1,4-oksatsiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset

Info

Publication number
FI952802A0
FI952802A0 FI952802A FI952802A FI952802A0 FI 952802 A0 FI952802 A0 FI 952802A0 FI 952802 A FI952802 A FI 952802A FI 952802 A FI952802 A FI 952802A FI 952802 A0 FI952802 A0 FI 952802A0
Authority
FI
Finland
Prior art keywords
piperidine
preparation
pharmaceutical compositions
compositions containing
oxazine compounds
Prior art date
Application number
FI952802A
Other languages
English (en)
Swedish (sv)
Other versions
FI952802A (fi
FI111948B (fi
Inventor
Jean-Louis Peglion
Joel Vian
Bertrand Goument
Mark Millan
Valerie Audinot
Jean-Charles Schwartz
Pierre Sokoloff
Original Assignee
Adir
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir, Inst Nat Sante Rech Med filed Critical Adir
Publication of FI952802A0 publication Critical patent/FI952802A0/fi
Publication of FI952802A publication Critical patent/FI952802A/fi
Application granted granted Critical
Publication of FI111948B publication Critical patent/FI111948B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI952802A 1994-06-08 1995-06-07 Uudet tetrasykliset piperidiini- ja 1,4-oksatsiiniyhdisteet FI111948B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9406985 1994-06-08
FR9406985A FR2721027B1 (fr) 1994-06-08 1994-06-08 Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant.

Publications (3)

Publication Number Publication Date
FI952802A0 true FI952802A0 (fi) 1995-06-07
FI952802A FI952802A (fi) 1995-12-09
FI111948B FI111948B (fi) 2003-10-15

Family

ID=9463983

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952802A FI111948B (fi) 1994-06-08 1995-06-07 Uudet tetrasykliset piperidiini- ja 1,4-oksatsiiniyhdisteet

Country Status (17)

Country Link
US (2) US5593989A (fi)
EP (1) EP0686637B1 (fi)
JP (1) JP3157418B2 (fi)
CN (1) CN1050358C (fi)
AT (1) ATE192155T1 (fi)
AU (1) AU681780B2 (fi)
CA (1) CA2151096C (fi)
DE (1) DE69516457T2 (fi)
DK (1) DK0686637T3 (fi)
ES (1) ES2147825T3 (fi)
FI (1) FI111948B (fi)
FR (1) FR2721027B1 (fi)
GR (1) GR3033762T3 (fi)
NO (1) NO304741B1 (fi)
NZ (1) NZ272298A (fi)
PT (1) PT686637E (fi)
ZA (1) ZA954738B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741074B1 (fr) * 1995-11-09 1997-12-19 Adir Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0988289A2 (en) * 1997-06-05 2000-03-29 Takeda Pharmaceutical Company Limited Heterocyclic compounds, their production and use
AU2004230841A1 (en) * 2003-04-03 2004-10-28 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
FR2906249B1 (fr) 2006-09-26 2008-12-19 Servier Lab Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
US4435231A (en) * 1982-03-31 1984-03-06 The United States Of America As Represented By The United States Department Of Energy Cold worked ferritic alloys and components
DE3583307D1 (en) * 1984-05-10 1991-08-01 Ciba Geigy Ag Benzo-(pyrano und thiopyrano)-pyridine.
US4774243A (en) * 1985-12-24 1988-09-27 Merck & Co., Inc. Dopamine agonists for treating elevated intraocular pressure
US4792548A (en) * 1986-05-21 1988-12-20 Warner-Lambert Company Trans-benzopyran-(4,3-b)-1,4-oxazine derivatives, intermediates and pharmaceutical use
US5294618A (en) * 1989-07-28 1994-03-15 Merck Sharp & Dohme Limited Octahydrobenzisoquinoline derivatives as antipsychotic agents
WO1993024471A1 (en) 1992-06-02 1993-12-09 Whitby Research, Inc. Substituted naphthoxazines useful as dopaminergics

Also Published As

Publication number Publication date
NZ272298A (en) 1996-05-28
EP0686637A1 (fr) 1995-12-13
NO952249L (no) 1995-12-11
US5593989A (en) 1997-01-14
JPH07330778A (ja) 1995-12-19
DE69516457D1 (de) 2000-05-31
FR2721027A1 (fr) 1995-12-15
US5668142A (en) 1997-09-16
CA2151096A1 (fr) 1995-12-09
ZA954738B (en) 1996-01-26
CN1120541A (zh) 1996-04-17
NO952249D0 (no) 1995-06-07
CN1050358C (zh) 2000-03-15
DK0686637T3 (da) 2000-09-18
NO304741B1 (no) 1999-02-08
ES2147825T3 (es) 2000-10-01
GR3033762T3 (en) 2000-10-31
CA2151096C (fr) 2003-07-08
DE69516457T2 (de) 2001-01-18
JP3157418B2 (ja) 2001-04-16
EP0686637B1 (fr) 2000-04-26
AU2052395A (en) 1995-12-14
ATE192155T1 (de) 2000-05-15
FR2721027B1 (fr) 1996-07-19
PT686637E (pt) 2000-08-31
FI952802A (fi) 1995-12-09
FI111948B (fi) 2003-10-15
AU681780B2 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
ATE233559T1 (de) Verwendung von benzothiophene zur behandlung von hypercholesterolämie
FI952802A0 (fi) Uudet tetrasykliset piperidiini- ja 1,4-oksatsiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
PL311845A1 (en) 5-acyl 1,4-dihydropyridine derivatives, method of obtaining them, their application and drugs containing such derivatives
FI950138A (fi) Uusia 4-(3-bentsofuranyyli)piperidinyyli- ja 4-(3-bentsotienyyli)piperidinyylijohdannaisia ja niitä sisältäviä farmaseuttisia koostumuksia
HUT39741A (en) Process for preparing pyridine derivatives and pharmaceutical compositions containing such compounds as active ingredients
NO964672D0 (no) Nye tetracykliske 1,4-oksazinforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger innholdende dem
PT89000A (pt) Processo para a preparacao de composicoes farmaceuticas e veterinarias analgesicas contendo pirimidinas
DK0899267T3 (da) Disubstituerede trans-3,4,4a,5,6,10b-hexahydro-2H-napht[1,2-b]-1,4-oxiner, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende disse
ES8307788A1 (es) Procedimiento perfeccionado para la fabricacion de derivadosde la quinolina
DE3867563D1 (en) 2-amino-5-hydroxy-4-pyrimidone.
DK0829470T3 (da) 2-Cyano-3,5-dihydroxy-hex-2-en-carboxylsyreamidderivater, fremgangsmåde til deres fremstilling og deres anvendelse som læge
ATE5724T1 (de) Guanidinverbindungen, verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
SE8406046D0 (sv) New azabiocyclic compounds and a process for the preparation thereof
ES8603846A1 (es) Procedimiento de preparacion de nuevos derivados a-etilami- noetoxibencilalcoholicos con un grupo fenil sustituido en situacion a y de sus sales de adicion acidas y amonicas cua-ternarias
FI951296A0 (fi) Uudet aminoalkyylibentsotiatsolinonit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset

Legal Events

Date Code Title Description
MA Patent expired